Phase I oncology trials: risks and benefits vary by trial type

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1042卷 / 1期
关键词：
Public Health; Toxic Event; Cancer Therapy; Chemotherapeutic Agent; Stable Disease;
D O I：
10.2165/00128415-200510420-00010
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [41] Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?
    Fountzilas, Christos
    Stuart, Selena
    Hernandez, Brian
    Bowhay-Carnes, Elizabeth
    Michalek, Joel
    Sarantopoulos, John
    Karnad, Anand
    Patel, Sukeshi
    Weitman, Steven
    Mahalingam, Devalingam
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) : 386 - 391
  • [42] Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?
    Christos Fountzilas
    Selena Stuart
    Brian Hernandez
    Elizabeth Bowhay-Carnes
    Joel Michalek
    John Sarantopoulos
    Anand Karnad
    Sukeshi Patel
    Steven Weitman
    Devalingam Mahalingam
    Investigational New Drugs, 2017, 35 : 386 - 391
  • [43] The role of the expansion cohort in phase I trials in oncology: Guidelines of the phase I HUB
    Ezzalfani, Monia
    Dugue, Audrey
    Mollevi, Caroline
    Pulido, Marina
    Bonnetain, Franck
    Filleron, Thomas
    Gal, Jocelyn
    Gauthier, Melanie
    Le Deley, Marie Cecile
    Le Tourneau, Christophe
    Medioni, Jacques
    Nguyen, Jean-Michel
    Chabaud, Sylvie
    Teixeira, Luis
    Thivat, Emilie
    You, Benoit
    Kramar, Andrew
    Paoletti, Xavier
    BULLETIN DU CANCER, 2015, 102 (01) : 73 - 82
  • [44] A PHASE-I TRIAL ON THE ETHICS OF PHASE-I TRIALS
    EMANUEL, EJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1049 - 1051
  • [45] Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience
    Glass, C.
    Den, R. B.
    Dicker, A. P.
    Lawrence, Y. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S65 - S65
  • [46] Phase I trials in oncology: a new era has started
    Postel-Vinay, S.
    Soria, J. -C.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 7 - 9
  • [47] Phase I clinical trials in oncology: a moral dilemma for the investigators
    Seligmann, M
    PRESSE MEDICALE, 2003, 32 (04): : 147 - 148
  • [48] Trends in the use and role of biomarkers in phase I oncology trials
    Goulart, Bernardo H. L.
    Clark, Jeffrey W.
    Pien, Homer H.
    Roberts, Thomas G.
    Finkelstein, Stan N.
    Chabner, Bruce A.
    CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6719 - 6726
  • [49] Defining the Research Category in Pediatric Phase I Oncology Trials
    Lad, Pramod M.
    Dahl, Rebecca
    Accountability in Research-Policies and Quality Assurance, 2015, 22 (03): : 139 - 147
  • [50] Improving Patient Selection for Phase I Oncology Trials Reply
    Hyman, David M.
    Eaton, Anne A.
    Gounder, Mrinal M.
    Ivy, S. Percy
    Iasonos, Alexia
    Spriggs, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (28) : 3199 - U288
12345